Familial adenomatous polyposis

Search Trials
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy – ACE Inhibitor Therapy Trial
Status:
Completed
Last Changed:
May 4, 2015
First Changed:
May 4, 2015
Disease(s):
Myocardial Fibrosis
Intervention(s):
Enalapril
The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy
Status:
Terminated
Last Changed:
Jan 14, 2020
First Changed:
Jan 12, 2016
Disease(s):
Muscular Dystrophy
Intervention(s):
Tadalafil 20 MGbeetroot juice extract
Mother-caregivers of Children With Duchenne Muscular Dystrophy
Status:
Completed
Last Changed:
Feb 3, 2016
First Changed:
Aug 13, 2013
Disease(s):
Other Diseases or Conditions
Intervention(s):
sleep parametersHormonal profileInflammatory profileCardiovascular profileMetabolic profile
Endoscopic Evaluation of Duodenal Polyposis in Patients With Familial Adenomatous Polyposis (FAP)
Status:
Completed
Last Changed:
Feb 13, 2020
First Changed:
Nov 20, 2017
Disease(s):
Familial Adenomatous Polyposes
Intervention(s):
Esophagogastroduodenoscopy
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
Status:
Completed
Last Changed:
Sep 29, 2020
First Changed:
Jan 27, 2003
Disease(s):
Colorectal Cancer
Intervention(s):
CelecoxibPlaceboeflornithineLaboratory biomarker analysisQuestionnaire administration
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Status:
Completed
Last Changed:
Jun 17, 2016
First Changed:
Aug 24, 2010
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
ErlotinibSulindacPlacebo APlacebo B
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Status:
Terminated
Last Changed:
Sep 20, 2019
First Changed:
Sep 1, 2005
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
MK0966; rofecoxib / Duration of Treatment: 24 weeksComparator: placebo / Duration of Treatment: 24 weeks
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Status:
Terminated
Last Changed:
Feb 21, 2021
First Changed:
Jan 3, 2008
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
CelecoxibPlacebo

Connect. Empower. Inspire.